Lysosomes

Why can a white blood cell swallow a bacterium and reduce it to rubble within minutes? Meanwhile the cell's own proteins survive for days. The answer sits inside a single membrane-bound sac called the lysosome. Every eukaryotic cell must dispose of worn-out organelles, misfolded proteins, invading microbes, and bulk macromolecules taken up from outside. It must do this without releasing destructive enzymes into the cytoplasm. Otherwise those enzymes would digest the cell itself. The lysosome solves this problem by combining two design features: it is acidic, and it is walled off. Lysosomes matter because they sit at the center of cellular quality control, nutrient recycling, immune defense, and programmed cell death. A cell without functioning lysosomes cannot clear damaged mitochondria. It also cannot present antigens to the immune system properly. Nor can it break down the very molecules it endocytoses for nutrition. In humans, defects in single lysosomal enzymes cause a devastating family of disorders. There are over 50 such inherited conditions, called the lysosomal storage diseases. In these diseases, undigested material piles up inside cells until organs fail. The big picture connects lysosomes to the rest of the endomembrane system explored through The Golgi Apparatus. Lysosomal enzymes are made in the rough endoplasmic reticulum. They are then tagged in the Golgi. Finally, they are shipped to a specialized acidic compartment where they become active. This article works through the mannose-6-phosphate tagging mechanism that sorts these enzymes correctly. It also covers the classic experiments that established the model. These include de Duve's discovery of lysosomes by "correcting" his own data, and the elucidation of the M6P pathway. The article provides worked numerical examples. It also examines the medical consequences of getting this system wrong. This sets up later discussions of Autophagy and plant/fungal Vacuoles.

Key takeaways
  • Lysosomes are membrane-bound organelles containing ~60 different acid hydrolases that digest proteins, lipids, nucleic acids, and carbohydrates.
  • Their interior is kept at pH ≈ 4.5–5.0 by a V-type ATPase proton pump; hydrolases are optimized for this acidic pH and largely inactive at cytosolic pH 7.2.
  • Enzymes are tagged with mannose-6-phosphate (M6P) in the cis-Golgi and sorted away from secretory proteins by M6P receptors in the trans-Golgi network.
  • Christian de Duve discovered lysosomes in 1955 through a cell-fractionation "accident," earning the 1974 Nobel Prize.
  • Lysosomes degrade material delivered by phagocytosis, endocytosis, and autophagy, and are essential for antigen processing, cholesterol handling, and developmental cell death.
  • Mutations in lysosomal enzymes or trafficking machinery cause lysosomal storage diseases (e.g., Tay-Sachs, I-cell disease, Gaucher disease).
The core insight

Lysosomes achieve safe, powerful intracellular digestion by physically isolating dozens of acid-optimized hydrolytic enzymes inside a membrane bag whose interior is actively pumped to pH ~4.5, so the enzymes work only where they are meant to.

The core idea

A lysosome is a membrane-enclosed organelle, typically 0.1–1.2 μm in diameter, found in essentially all animal cells (plants and fungi use a related but structurally distinct compartment, the vacuole). It contains a cocktail of roughly 50–60 acid hydrolases — enzymes including proteases (cathepsins), nucleases (DNases, RNases), lipases, glycosidases, phosphatases, and sulfatases — each capable of breaking a different class of macromolecule down into its monomeric building blocks. What unites all of them is a shared catalytic requirement: they work best at an acidic pH, generally between 4.5 and 5.0, and are markedly less active at the neutral pH (~7.2) of the surrounding cytosol. This pH dependence is not incidental; it is the organelle's safety mechanism. If a lysosome ruptures and spills its contents into the cytoplasm, the enzymes find themselves in a neutral environment where most of them are poor catalysts, limiting collateral damage to the cell. The acidic interior itself is generated and maintained by a vacuolar H⁺-ATPase (V-ATPase), a multi-subunit proton pump embedded in the lysosomal membrane that hydrolyzes ATP to actively transport H⁺ ions into the lumen against their concentration gradient. The lysosomal membrane itself is protected from self-digestion by an unusually thick coat of heavily glycosylated integral membrane proteins (LAMP-1, LAMP-2, LIMP-2) whose sugar chains shield the membrane's cytosolic-facing lipids and proteins from the very hydrolases they contain. Lysosomes are not a single static structure but a dynamic, heterogeneous population of vesicles collectively called the endolysosomal system, receiving material from three main routes: endocytosis (material from outside the cell, via early and late endosomes), phagocytosis (large particles like bacteria or apoptotic cell debris, engulfed by macrophages and neutrophils), and autophagy (the cell's own damaged organelles and protein aggregates, delivered via autophagosomes — the subject taken up more fully under Autophagy). All three converge on the lysosome as the final degradative destination, making it the digestive terminus of the entire endomembrane system.

Mechanism

Step 1 — Synthesis and initial glycosylation. Lysosomal enzymes are synthesized as preproproteins on ribosomes bound to the rough endoplasmic reticulum (ER), just like secreted and plasma-membrane proteins. As the nascent polypeptide is translocated into the ER lumen, an oligosaccharyltransferase complex adds a branched, 14-sugar N-linked oligosaccharide (Glc₃Man₉GlcNAc₂) to specific asparagine residues — the same generic tagging process used for essentially all glycoproteins destined for the endomembrane system.

Step 2 — The mannose-6-phosphate tag. The decisive sorting event happens in the cis-Golgi network. A phosphotransferase (GlcNAc-1-phosphotransferase) recognizes a shared three-dimensional signal patch — not a linear sequence — displayed only on the surface of properly folded lysosomal hydrolases, and transfers GlcNAc-phosphate onto specific mannose residues of their N-linked oligosaccharides. A second enzyme then removes the GlcNAc cap, exposing a free mannose-6-phosphate (M6P) group. This M6P tag is the molecular "address label" that marks a glycoprotein as lysosome-bound and distinguishes it from proteins destined for secretion or the plasma membrane.

Step 3 — Receptor-mediated sorting in the trans-Golgi network (TGN). In the TGN, M6P-tagged enzymes bind to mannose-6-phosphate receptors (MPRs), transmembrane proteins whose lumenal domain recognizes M6P at the mildly acidic pH of the TGN (~6.5). The cytosolic tails of MPRs are recognized by clathrin adaptor proteins (GGA and AP-1), which cluster the receptor-cargo complexes into clathrin-coated vesicles that bud from the TGN.

Step 4 — Delivery and receptor recycling. These vesicles shed their clathrin coat and fuse with late endosomes, whose lumen is more acidic (pH ~5.5–6.0). At this lower pH, M6P dissociates from its receptor — a pH-dependent conformational release, analogous to LDL release from its receptor in endosomes. The freed hydrolases remain in the maturing endosome/lysosome, while the empty MPR is packaged into transport vesicles and recycled back to the TGN to pick up a fresh load of enzymes. A small fraction of newly made hydrolases escape M6P tagging and are secreted by default; some of these are recaptured at the cell surface by a second population of M6P receptors and returned via endocytosis — a rescue pathway that is medically important (see I-cell disease, below).

Step 5 — Maturation and acidification. Late endosomes mature into lysosomes as V-ATPase density increases, luminal pH drops further to ~4.5–5.0, and hydrolases are proteolytically activated (many are made as zymogen-like proproteins, cleaved to their active mature form only once inside the acidic compartment). This is a further safety layer: even a hydrolase that leaked out prematurely into a neutral-pH compartment would often still be in its inactive zymogen form.

Step 6 — Digestion and export. Substrates delivered by endocytosis, phagocytosis, or autophagy are broken down into monomers — amino acids, monosaccharides, nucleotides, free fatty acids — which are exported across the lysosomal membrane by dedicated transporters into the cytosol for reuse in biosynthesis or energy metabolism. Indigestible residues can persist as residual bodies (seen in aged cells as lipofuscin granules) or be exocytosed.

Figure
Trafficking of a lysosomal hydrolase from the ER to the lysosome via the M6P tag
Rough ER hydrolase + N-glycan Golgi (cis to trans) phosphotransferase adds GlcNAc-P M6P tag exposed (TGN) MPR + clathrin Late endosome (pH ~5.5) M6P releases from MPR Lysosome pH ~4.5 active acid hydrolases

The acidification machine in detail. The V-ATPase is a rotary molecular motor structurally related to (but distinct from) the mitochondrial ATP synthase. Its cytosolic V₁ domain hydrolyzes ATP, driving rotation of a central stalk that turns the membrane-embedded V₀ proteolysis, translocating protons one at a time into the lysosomal lumen. Because the lysosomal membrane also contains chloride channels (CLC-7) that allow counter-ion flux, charge neutrality is maintained and the pump can generate a large pH gradient — roughly 2.5–3 pH units, corresponding to a 300- to 1000-fold higher H⁺ concentration inside than in the cytosol — without an equally large, self-limiting electrical potential.

Figure
The acidic-hydrolase safety system: pH-dependent activity of a representative cathepsin
Cathepsin activity vs. pH Luminal / cytosolic pH Relative enzyme activity (%) 4.0 4.5 5.0 6.0 7.2 peak activity, lysosome near-inactive, cytosol lysosomal pH range

The evidence

De Duve's discovery of lysosomes (1949–1955): an "accident" that became a Nobel Prize. Christian de Duve, working in Louvain, was studying the enzyme glucose-6-phosphatase and its role in insulin action, using rat liver homogenates separated by differential centrifugation — spinning fractions at increasing speeds to pellet nuclei, then mitochondria, then microsomes. While assaying acid phosphatase activity (a marker enzyme unrelated to his original question) in these fractions, de Duve found something odd: freshly prepared fractions showed low enzyme activity, but activity increased several-fold if the fraction was left in the refrigerator for a few days, or was disrupted with detergents. The straightforward interpretation was that the enzyme was latent — physically enclosed inside an intact membrane barrier that had to be broken (by aging, freeze-thaw, or detergent) before substrate could reach the enzyme. Further fractionation showed that acid phosphatase, along with several other hydrolytic enzymes (cathepsins, ribonuclease, β-glucuronidase), co-sedimented together in a fraction distinct from mitochondria, with a characteristic density on sucrose gradients. De Duve named this new class of organelle the lysosome ("digestive body") in 1955. Electron microscopy, done in collaboration with Alex Novikoff, subsequently confirmed the existence of these membrane-bound, enzyme-rich vesicles as a morphologically distinct organelle, closing the loop between biochemical fractionation and direct visualization. De Duve received the 1974 Nobel Prize in Physiology or Medicine (shared with Albert Claude and George Palade) for this and his subsequent work characterizing peroxisomes. The key experimental proof of "latency" is worth stating precisely, because it is a model of how biochemistry can reveal something no microscope had yet shown: measured activity of acid phosphatase in a fresh, gently prepared mitochondrial-lysosomal fraction was low; the same fraction, after mechanical disruption (osmotic shock or detergent treatment) or several days of storage, showed up to 10-fold higher measurable activity with no change in the total amount of enzyme protein present. Because total enzyme content was constant while measurable activity rose only after membrane-breaking treatments, the simplest explanation was that the enzyme had been physically sequestered behind a membrane that excluded substrate — direct biochemical evidence for a membrane-bound digestive compartment, discovered before it was ever seen.

Elucidating the mannose-6-phosphate pathway (1970s–1980s): Kornfeld, Neufeld, and I-cell disease. The M6P sorting signal was worked out largely through the study of a human genetic disease. Elizabeth Neufeld and colleagues, studying mucolipidosis II (I-cell disease), found that patients' fibroblasts massively over-secreted lysosomal enzymes into the culture medium instead of retaining them intracellularly, while the cells themselves accumulated dense "inclusion bodies" (giving the disease its name — "I-cell"). Crucially, when Neufeld's group added normal fibroblast-conditioned medium (containing correctly tagged secreted enzymes) to I-cell fibroblasts, the diseased cells took up the enzymes and correctly delivered them to lysosomes — showing that I-cell fibroblasts had a functional uptake receptor but were making enzymes that lacked the correct tag. Stuart Kornfeld's laboratory then identified the missing tag as mannose-6-phosphate and showed that I-cell disease is caused by loss-of-function mutations in the GlcNAc-1-phosphotransferase gene itself, so lysosomal enzymes are synthesized normally but never receive the M6P address label, are mis-sorted for default secretion, and lysosomes in affected tissues become swollen with undigested substrate. This combination of cell biology (uptake/correction experiments) and biochemistry (identifying the sugar-phosphate tag and its enzyme) established the M6P pathway as the central sorting mechanism for soluble lysosomal proteins — a landmark case of a rare disease illuminating a universal cell-biological mechanism.

Worked examples

Example 1 — Interpreting a subcellular fractionation experiment. A researcher homogenizes rat liver and separates it by differential centrifugation into four fractions: nuclear (600 × g, 10 min), heavy mitochondrial (containing lysosomes, 15,000 × g, 20 min), light microsomal (100,000 × g, 60 min), and soluble cytosol. She assays acid phosphatase activity in each fraction, both before and after treating each with 0.1% Triton X-100 (a detergent that disrupts membranes).

FractionActivity, intact (units)Activity, +Triton (units)
Nuclear56
Heavy mitochondrial12118
Light microsomal34
Cytosol22

Reasoning: Total enzyme in a fraction should not change with detergent — only its accessibility to substrate should. The heavy mitochondrial fraction shows a ~10-fold jump in measured activity after detergent treatment (12 → 118), while the other fractions barely change. This asymmetric, fraction-specific "unmasking" is the latency signature de Duve used: the enzyme in the heavy mitochondrial fraction is enclosed by an intact membrane in most vesicles, and only becomes fully accessible to substrate once that membrane is dissolved. Because this fraction also contains mitochondria, a differential marker is needed to distinguish the two organelles — the researcher would additionally assay a mitochondrial marker enzyme (e.g., succinate dehydrogenase, which shows little or no latency, since it's an integral inner-membrane enzyme already accessible after standard homogenization) to confirm that the acid phosphatase pool is a separate, lysosome-containing population rather than a mitochondrial contaminant. This is precisely the logic de Duve used to first infer lysosomes existed before they were seen by electron microscopy.

Example 2 — Diagnosing a lysosomal storage disease from clinical and biochemical clues. A 14-month-old infant presents with coarse facial features, corneal clouding, restricted joint mobility, and developmental regression. Serum levels of several lysosomal enzymes (hexosaminidase, β-galactosidase, arylsulfatase) are found to be markedly elevated — the opposite of what one would first guess for a "lysosomal deficiency" disease — while enzyme activities measured directly inside cultured skin fibroblasts are all severely reduced. Electron microscopy of fibroblasts shows lysosomes distended with fibrogranular storage material ("inclusion bodies"). Reasoning: If enzymes were absent because of mutations in each individual hydrolase gene, you would not expect multiple, unrelated enzymes to be simultaneously affected — that would require an implausible coincidence of several independent mutations. The pattern instead points to a single upstream defect affecting the sorting of many enzymes at once: elevated serum activity plus low intracellular activity is the classic signature of enzymes being made normally but mis-secreted rather than delivered to lysosomes. This is exactly the phenotype of I-cell disease (mucolipidosis II), caused by mutation of GlcNAc-1-phosphotransferase, the enzyme that attaches the mannose-6-phosphate tag. Without the tag, dozens of different hydrolases fail to bind mannose-6-phosphate receptors in the trans-Golgi network, are packaged into the default secretory pathway instead, and accumulate outside cells (raising serum levels) while lysosomes inside cells — starved of their enzymes — fill up with undigested glycosaminoglycans and glycolipids (producing the inclusion bodies and the storage-disease phenotype). Correct diagnosis requires recognizing that a sorting-signal defect masquerades biochemically as multiple simultaneous enzyme deficiencies.

Common misconceptions & traps

MisconceptionWhy it's wrong
"Lysosomes only digest material from outside the cell (endocytosed/phagocytosed)."Lysosomes are equally central to autophagy — digesting the cell's own worn-out organelles and misfolded proteins — a major route explored under Autophagy.
"Lysosomal enzymes are inactive until they reach the lysosome, full stop."They are synthesized as active-capable proteins from the start; what's regulated is access to substrate (via compartmentalization) and pH-dependent catalytic efficiency, plus proteolytic maturation of some proenzymes.
"The mannose-6-phosphate tag is added to every lysosomal protein, including membrane proteins like LAMP-1."M6P tagging sorts soluble lumenal hydrolases; lysosomal membrane proteins (LAMPs, LIMPs) use distinct sorting signals in their cytosolic tails, recognized by different adaptor complexes.
"If lysosomes rupture, the cell is doomed instantly because the enzymes are so powerful."Because hydrolases are pH-optimized for ~4.5–5.0 and are far less active at cytosolic pH 7.2, limited leakage is often tolerated; only extensive rupture (as in some forms of cell death) causes rapid, uncontrolled digestion.
"Lysosomes are static organelles with a fixed size and enzyme content."Lysosomes are dynamic, fuse and re-form constantly with endosomes and autophagosomes, and vary substantially in size, number, and enzyme complement between cell types and physiological states.

The scientist behind it

Christian de Duve trained as a physician and biochemist in Belgium, and spent much of his early career working on insulin's mechanism of action at the Catholic University of Louvain. His discovery of the lysosome grew directly out of methodical, almost tedious enzyme-fractionation work rather than a targeted search for a new organelle — a case study in how rigorous quantitative control experiments (repeating assays, tracking total protein and total activity across fractions) can reveal structures invisible to the microscopes of the time. De Duve later coined not only "lysosome" but also "peroxisome" and "autophagy," shaping the vocabulary of organelle biology for generations. He remained active in cell biology and origin-of-life research well into his nineties, and became a prominent public voice on the ethics of aging and end-of-life care.

Origins · 1 minChristian René de Duve and how this was discovered
CR
Christian René de Duve
1917–2013 · Belgian cytologist and biochemist, University of Louvain; discovered lysosomes and peroxisomes via subcellular fractionation; shared the 1974 Nobel Prize in Physiology or Medicine with Albert Claude and George Palade

History
- 1949 — de Duve begins subcellular fractionation studies of rat liver to investigate insulin and glucose-6-phosphatase.
- 1955 — de Duve identifies the lysosome as a distinct, enzyme-latent organelle based on acid phosphatase behavior; coins the name.
- 1955 — Alex Novikoff obtains electron micrographs confirming lysosomes as a morphologically distinct membrane-bound organelle.
- 1968 — Elizabeth Neufeld and colleagues begin uncovering enzyme cross-correction between mucopolysaccharidosis patient cell lines, laying groundwork for the M6P discovery.
- 1977–1981 — Stuart Kornfeld's laboratory identifies mannose-6-phosphate as the lysosomal targeting tag and links its absence to I-cell disease.
- 1974 — de Duve awarded the Nobel Prize in Physiology or Medicine.

Where this matters today

Enzyme replacement therapy (ERT). Understanding the M6P pathway made it possible to treat several lysosomal storage diseases by infusing recombinant enzyme intravenously. Because circulating M6P receptors on cell surfaces can take up extracellular enzyme and deliver it to lysosomes (the very mechanism Neufeld exploited in her cross-correction experiments), enzymes like recombinant glucocerebrosidase (for Gaucher disease) and alglucosidase alfa (for Pompe disease) can be engineered with M6P-rich glycosylation and delivered as drugs, restoring partial lysosomal function in affected tissues.

Cancer biology. Many tumor cells co-opt lysosomal proteases (cathepsins) and increase lysosomal exocytosis to degrade the extracellular matrix, facilitating invasion and metastasis; lysosomal membrane permeabilization is also studied as a trigger for a form of programmed cell death, making lysosomes a target for anticancer drug development.

Neurodegeneration. Impaired lysosomal/autophagic clearance of aggregated proteins (α-synuclein, tau, huntingtin) is implicated in Parkinson's, Alzheimer's, and Huntington's disease; mutations in the lysosomal enzyme glucocerebrosidase (GBA) are the single strongest known genetic risk factor for Parkinson's disease after age.

Antibiotic and antiviral targeting. Many pathogens (Mycobacterium tuberculosis, Salmonella, some viruses) survive inside host cells specifically by blocking or subverting lysosomal fusion and acidification; understanding this arms race informs drugs that force pathogen-containing vacuoles to mature and fuse with lysosomes.

Diagnosis and newborn screening. Direct enzyme assays and, increasingly, tandem mass spectrometry newborn screening panels detect lysosomal storage diseases (Pompe, Fabry, MPS I) early enough for enzyme replacement or substrate-reduction therapy to meaningfully alter disease course.

Ask the tutor: How does the cell distinguish "digest this" (lysosomal delivery) from "secrete this" for two similarly folded glycoproteins in the Golgi?

Are lysosomes the same thing as vacuoles in plant cells?

Not quite, though they are related in function. Lysosomes are typically small (0.1–1.2 μm), numerous, acidic organelles found in animal cells, dedicated mainly to targeted digestion. Plant and fungal cells instead usually have one or a few large central vacuoles that can occupy 30–90% of cell volume, combining digestive functions with roles in turgor pressure, storage of ions and metabolites, and pigment storage. Both compartments share an acidic lumen, a V-ATPase, and hydrolytic enzymes, and both arise from the endomembrane system, but the vacuole takes on additional structural and homeostatic roles that lysosomes do not. This comparison is explored further under Vacuoles.

How is a lysosome different from a peroxisome?

Both are single-membrane organelles involved in breaking down molecules, and both were discovered by Christian de Duve, but they differ in origin, enzymes, and function. Lysosomes contain acid hydrolases, are acidic (~pH 4.5–5), and receive their enzymes via the Golgi/M6P pathway from the ER. Peroxisomes contain oxidative enzymes (catalase, various oxidases), are not markedly acidic, generate and detoxify hydrogen peroxide, and import their enzymes directly from the cytosol via a distinct signal (the PTS1/PTS2 peroxisomal targeting sequence) without ever passing through the ER or Golgi. Functionally, peroxisomes specialize in fatty acid β-oxidation and reactive oxygen species detoxification rather than general macromolecule digestion.

What happens to the amino acids, sugars, and lipids produced by lysosomal digestion?

They don't stay in the lysosome. Dedicated transport proteins embedded in the lysosomal membrane export the monomeric products — free amino acids, monosaccharides, nucleosides, and fatty acids — into the cytosol. From there, the cell can reuse them: amino acids for new protein synthesis, sugars for glycolysis or glycogen/starch synthesis, and fatty acids for membrane building or beta-oxidation in mitochondria. This recycling is especially critical during starvation or stress, when autophagy ramps up specifically to liberate nutrients from the cell's own components, a theme developed further under Autophagy.

Why does mannose-6-phosphate work as a sorting signal instead of just a protein sequence tag, like a nuclear localization signal?

Because the M6P tag is added post-translationally to a carbohydrate modification rather than encoded directly in the amino acid sequence, it requires an extra layer of enzymatic recognition. The GlcNAc-1-phosphotransferase must recognize a shared three-dimensional structural signature (a patch of lysine residues plus surrounding secondary structure) common to dozens of otherwise unrelated hydrolases, since they don't share a linear peptide motif. This is actually advantageous: it lets one recognition system tag a chemically diverse set of proteins for a single destination, using sugar chemistry as a universal "barcode" read out later by mannose-6-phosphate receptors, rather than requiring a separate peptide signal evolved independently for each of the ~60 hydrolases.

Can lysosomes fuse directly with the plasma membrane?

Yes, in a regulated process called lysosomal exocytosis. In response to a rise in intracellular calcium (often triggered by membrane damage or, in specialized cells, by physiological signals), lysosomes can move to the cell periphery and fuse with the plasma membrane, releasing their contents extracellularly and simultaneously helping reseal damaged patches of membrane. This is used physiologically by osteoclasts (which secrete lysosomal enzymes to dissolve bone matrix) and cytotoxic T cells and NK cells (which secrete perforin and granzymes from lysosome-related organelles called lytic granules to kill target cells).

Why do lysosomal storage diseases so often affect the brain severely?

Neurons are long-lived, post-mitotic cells that cannot dilute accumulating storage material through cell division, and they are especially dependent on efficient lysosomal turnover of complex lipids like gangliosides, which are abundant in neuronal membranes. When a specific hydrolase is missing (e.g., hexosaminidase A in Tay-Sachs disease), its substrate accumulates progressively inside neuronal lysosomes over months to years, distending them and eventually causing neuronal dysfunction and death. Because neurons cannot be replaced, and because many disease-causing enzymes act on lipids concentrated in neural tissue, the central nervous system often bears the brunt of clinical severity even when the underlying enzyme is expressed in every cell type in the body.

Is the mannose-6-phosphate pathway the only way proteins reach lysosomes?

No. M6P tagging is the major route for soluble lumenal hydrolases, but several important exceptions exist. Lysosomal membrane proteins (like LAMP-1/2) use short cytosolic-tail sorting signals (often containing a critical tyrosine or dileucine motif) recognized by adaptor protein complexes, bypassing M6P entirely. Some enzymes reach lysosomes by M6P-independent routes involving alternative sorting receptors (such as sortilin). And material can also reach the lysosome without ever being "sorted" as cargo at all — by direct membrane fusion of endosomes, phagosomes, or autophagosomes, which deliver whatever they contain regardless of any tag.

Before this

Where this leads